These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17596313)

  • 1. Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein.
    Yi CR; Rosenberg N
    J Virol; 2007 Sep; 81(17):9461-8. PubMed ID: 17596313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations affecting the MA portion of the v-Abl protein reveal a conserved role of Gag in Abelson murine leukemia virus (MLV) and Moloney MLV.
    Yi CR; Rosenberg N
    J Virol; 2008 Jun; 82(11):5307-15. PubMed ID: 18367522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
    Warren D; Griffin DS; Mainville C; Rosenberg N
    J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carboxyl terminus of v-Abl protein can augment SH2 domain function.
    Warren D; Heilpern AJ; Berg K; Rosenberg N
    J Virol; 2000 May; 74(10):4495-504. PubMed ID: 10775585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
    Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
    J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
    Banerjee A; Rothman P
    J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of p53 complements defects in Abelson murine leukemia virus signaling.
    Unnikrishnan I; Rosenberg N
    J Virol; 2003 Jun; 77(11):6208-15. PubMed ID: 12743277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the Shc/Grb2 complex during abelson virus transformation affects proliferation, but not apoptosis.
    Baughn LB; Rosenberg N
    J Virol; 2005 Feb; 79(4):2325-34. PubMed ID: 15681433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gag-derived but not abl-derived determinants are exposed on the surface of Abelson virus-transformed cells.
    Schiff-Maker L; Rosenberg N
    Virology; 1986 Oct; 154(2):286-301. PubMed ID: 3020782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts.
    Daley GQ; McLaughlin J; Witte ON; Baltimore D
    Science; 1987 Jul; 237(4814):532-5. PubMed ID: 2440107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
    Rees-Jones RW; Goff SP
    J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation.
    Parmar K; Rosenberg N
    J Virol; 1996 Feb; 70(2):1009-15. PubMed ID: 8551558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.
    Watanabe SM; Rosenberg NE; Witte ON
    J Virol; 1984 Sep; 51(3):620-7. PubMed ID: 6088787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus.
    Prywes R; Hoag J; Rosenberg N; Baltimore D
    J Virol; 1985 Apr; 54(1):123-32. PubMed ID: 2983109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation within the kinase domain of v-abl gene responsible for temperature-sensitive colony-forming ability in soft agar.
    Soma T; Tsukada S; Oka Y; Kishimoto T; Sugiyama H
    Virology; 1993 Apr; 193(2):967-70. PubMed ID: 8460498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells.
    Gong L; Unnikrishnan I; Raghavan A; Parmar K; Rosenberg N
    J Virol; 2004 Feb; 78(4):1636-44. PubMed ID: 14747529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
    Mysliwiec T; Perego R; Kruh GD
    Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo.
    Zou X; Cong F; Coutts M; Cattoretti G; Goff SP; Calame K
    Mol Cell Biol; 2000 Jan; 20(2):628-33. PubMed ID: 10611241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of v-Fgr myristoylation and the Gag domain in membrane binding and cellular transformation.
    Baker SJ; Cosenza SC; Reddy EP
    Virology; 1998 Sep; 249(1):1-11. PubMed ID: 9740771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation.
    Prywes R; Foulkes JG; Rosenberg N; Baltimore D
    Cell; 1983 Sep; 34(2):569-79. PubMed ID: 6193890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.